Medtronic stock at EUR 79.28 with 2.9 times average volume

Published on 10/12/2026 at 14:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medtronic stock costs EUR 79.28 on October 12, 2026, 1.28 percent above EUR 78.28. Market cap is USD 113.3 billion; results follow November 24, 2026.

Key points in brief

Medtronic stock was EUR 79.28 at Lang & Schwarz on October 12, 2026, up 1.28 percent versus the Xetra close of EUR 78.28.
The latest USD 113.3 billion market capitalization and 21.8 price-to-earnings ratio are based on the October 9 NYSE quote.
The next earnings date is November 24, 2026, while Barclays set a USD 95.00 target and an Equal Weight rating.

Flatlay mit Aktienzertifikat, ISIN-Karte, Stethoskop und medizinischen Utensilien — Medtronic plc (ISIN IE00BTN1Y115) Flatlay kombiniert Aktienzertifikat, ISIN-Karte, Stethoskop und medizinische Utensilien, Illustration mit AI erstellt.

Medtronic plc (ISIN IE00BTN1Y115) was trading at EUR 79.28 at Lang & Schwarz on October 12, 2026 at 2:16 p.m. CEST, up 1.28 percent, or EUR 1.00, versus the Xetra close of October 9, 2026 at EUR 78.28. The euro quote places the stock above the last completed Xetra session while the US listing remains the primary market reference for valuation.

Price sits inside the yearly range

On the NYSE, Medtronic last traded at USD 88.48 on October 9, 2026 at 4:00 p.m. ET. The USD 73.31 to USD 106.33 52-week range puts the US quote USD 17.85 below its yearly high, a 16.79 percent gap calculated in the same currency.

Trading volume for that NYSE session was 38,860,319 shares versus an average of 13,548,212, or 2.87 times the average. The difference gives the price report a clear liquidity context even though the Lang & Schwarz quote is stated in euros.

Valuation and analyst target

Medtronic carried a USD 113.3 billion market capitalization, a 21.8 price-to-earnings ratio and a 3.00 percent dividend yield on the October 9 US quote. The next earnings date is November 24, 2026, according to TradingView.

Business Insider reported on October 6, 2026 that Barclays began coverage with an Equal Weight rating and a USD 95.00 price target. That target is USD 6.52 above the October 9 NYSE price, but the currencies are not combined with the euro quote.

Comparison with peers

Medtronic plc: plus 1.28 percent, P/E 21.8, market capitalization USD 113.3 billion
Abbott Laboratories (NYSE, USD): plus 1.13 percent, P/E 32.0, market capitalization USD 172.3 billion
Stryker Corporation (NYSE, USD): plus 0.13 percent, P/E 28.7, market capitalization USD 106.3 billion

Latest quote and market position

The October 12 Lang & Schwarz price of EUR 79.28 stands EUR 1.00 above the Xetra close of October 9, 2026, with the 1.28 percent change calculated from those two euro values. The US quote, valuation measures and peer figures remain separate currency-based context for the medical technology company.

The further course of trading is shown by the continuously updated real-time quote of Medtronic stock.